Upon antigen stimulation, it is possible that ADGRG1, as a member of the ZNF683 regulatory network, participates in the modulation of T cell effector function and NK transition, mediating the unique phenotype of AML tumor-reactive T cells. The gene discussed is ZNF683; the disease is acute myeloid leukemia.